The European Pregnancy Testing Market was worth USD 2.6 Billion in 2023. The European market size is anticipated to be worth USD 3.5 billion by 2029 from USD 2.73 billion in 2024, growing at a CAGR of 5.06% from 2024 to 2029.
Technological advancements in gynecology, pregnancy for the first time at a young age, rising infertility, gynecological problems, self-contained tests, and more prolonged laboratory procedures are all propelling the European pregnancy testing market forward.
Manufacturers concentrate on new product releases, market expansions, mergers, and partnerships, all of which positively impact the pregnancy testing market. Whether planned or not, Pregnancies have raised awareness among women, providing enormous growth prospects for essential participants. Furthermore, the qualitative analysis allows its stakeholders to profit from market possibilities at a specific period. The growing working population across Europe, rising disposable income, and supportive government measures are all expected to boost the pregnancy testing market in Europe in the coming years.
Coronavirus illness (COVID-19) is a global public health crisis. COVID-19 has left an indelible mark across various industries, including healthcare. Following the lockout, some patients began visiting hospitals for pregnancy tests, resulting in a surge in demand for pregnancy testing gadgets. Industry manufacturers are producing devices to satisfy the needs of hospitals and patients. The market for pregnancy tests is expected to develop at the fastest rate during the forecast period, owing to the rising demand.
High costs associated with the pregnancy kits are significant factors slowing the rate of adaptation in the European region. During the forecast period, a woman's lack of fundamental knowledge about pregnancy test kits would significantly impede the market's growth. Throughout the forecast period, factors such as PCOS and a lack of ovulation confirmation using ovulation prediction kits are expected to restrain the development of the European pregnancy testing market. There are several hurdles in perinatology in today's world, such as heart diseases, renal malfunction, and malformations, and testing is being done to overcome these risks during pregnancy. Immunotherapy is used when a person's immune system targets their own body.
This research report on the European pregnancy testing market has been segmented and sub-segmented into the following categories.
Europe Pregnancy Testing Market - By Product:
Europe Pregnancy Testing Market - By Test Type:
Europe Pregnancy Testing Market - By Distribution Channel:
Europe Pregnancy Testing Market - By Country:
In 2023, the European region accounted for the second-largest share in the global market. The increasing frequency of infertility and gynecological diseases and the accessibility of decentralized diagnostic procedures over time-consuming laboratory testing drive the European market for pregnancy and fertility devices. In addition, the market for pregnancy and fertility devices is growing due to technological developments, eye-catching product features, and an increase in the average age of first-time mothers.
Pregnancy and fertility devices have the second-largest market in Europe. The United Kingdom has the highest European pregnancy testing market, while Germany has the fastest-growing section. The United Kingdom is expected to lead the European Pregnancy Testing market during the forecast period. To expand market share, market players use various techniques such as product launches, development, collaborations, acquisitions, and expansions.
Germany had the second-largest proportion of the European pregnancy testing market in 2023. Unplanned pregnancies, increased awareness of pregnancy detection kits, rising personal care product expenditures, and significant industry players are boosting the market in this area.
KEY MARKET PLAYERS:
Companies playing a vital role in the European Pregnancy Testing Market are Abbott Laboratories, Cardinal Health, Church & Dwight, Germaine Laboratories, Kent Pharmaceuticals, Piramal Enterprises, Prestige Brands Holdings, Procter & Gamble Co., Quidel Corporation, and SPD Swiss Precision Diagnostics.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]